抗肿瘤咪唑并四嗪类化合物。VII. 高效液相色谱法对生物流体中米托蒽醌的定量分析。 - Suppr

Suppr

超能文献

Antitumour imidazotetrazines. VII. Quantitative analysis of mitozolomide in biological fluids by high-performance liquid chromatography.

作者信息

Slack J A, Goddard C

出版信息

J Chromatogr. 1985 Jan 11;337(1):178-81.

PMID:3980651

Abstract

摘要

相似文献

Antitumour imidazotetrazines. VII. Quantitative analysis of mitozolomide in biological fluids by high-performance liquid chromatography.抗肿瘤咪唑并四嗪类化合物。VII. 高效液相色谱法对生物流体中米托蒽醌的定量分析。

J Chromatogr. 1985 Jan 11;337(1):178-81.

Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in mice.抗肿瘤咪唑并四嗪类化合物，第九部分。米托蒽醌在小鼠体内的药代动力学。（注：原文中药物名称有误，正确的是“替莫唑胺（Temozolomide）”，这里按照你提供的错误名称“mitozolomide”翻译）

Br J Cancer. 1985 Jul;52(1):37-41. doi: 10.1038/bjc.1985.145.

Solvent-sample interactions in thermospray mass spectrometry of antineoplastic nitrogen mustards.

Biomed Environ Mass Spectrom. 1989 Apr;18(4):219-23. doi: 10.1002/bms.1200180403.

Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetry.抗肿瘤咪唑并四嗪类药物米托唑胺和替莫唑胺对细胞酯酶的抑制作用：流式细胞术和传统荧光分光光度法的证明

Cancer Chemother Pharmacol. 1989;25(3):149-55. doi: 10.1007/BF00689574.

High-performance liquid chromatographic separation and quantitation of benzisoquinolinedione (Nafidimide) from biological fluids.高效液相色谱法分离和定量生物流体中的苯并异喹啉二酮（萘酰亚胺）。

J Chromatogr. 1985 Dec 13;345(2):408-12. doi: 10.1016/0378-4347(85)80180-8.

Chemical stability of the new antitumour agent intoplicine in infusion fluids.

J Pharm Biomed Anal. 1993 Nov-Dec;11(11-12):1353-6. doi: 10.1016/0731-7085(93)80125-k.

Determination of linogliride in biological fluids by high-performance liquid chromatography.高效液相色谱法测定生物流体中的利诺列德

J Chromatogr. 1984 Nov 28;311(2):418-23. doi: 10.1016/s0378-4347(00)84740-4.

Antitumour imidazotetrazines--VIII. Uptake and decomposition of a novel antitumour agent mitozolomide (CCRG 81010; M and B 39565; NSC 353451) in TLX5 mouse lymphoma in vitro.抗肿瘤咪唑并四嗪类——VIII. 新型抗肿瘤药物米托蒽醌（CCRG 81010；M和B 39565；NSC 353451）在TLX5小鼠淋巴瘤细胞中的体外摄取与分解

Biochem Pharmacol. 1985 Jan 15;34(2):217-21. doi: 10.1016/0006-2952(85)90127-3.

[Use of ion-exchange sorbents for determining drug preparations and their metabolites in biological fluids by high-performance liquid chromatography].[离子交换吸附剂在高效液相色谱法测定生物流体中药物制剂及其代谢物中的应用]

Farmakol Toksikol. 1985 Nov-Dec;48(6):62-7.

Fully automated high-performance liquid chromatography. A new chromatograph for pharmacokinetic drug monitoring by direct injection of body fluids.全自动高效液相色谱法。一种通过直接注射体液进行药代动力学药物监测的新型色谱仪。

J Chromatogr. 1981 Jan 2;222(1):13-22.

引用本文的文献

Br J Cancer. 1985 Jul;52(1):37-41. doi: 10.1038/bjc.1985.145.

In vivo studies with the novel anticancer agent mitozolomide (NSC 353451) on Lewis lung carcinoma.新型抗癌药米托唑胺（NSC 353451）对Lewis肺癌的体内研究。

Cancer Chemother Pharmacol. 1986;16(2):125-8. doi: 10.1007/BF00256161.

Activity and distribution studies of etoposide and mitozolomide in vivo and in vitro against human choriocarcinoma cell lines.

Cancer Chemother Pharmacol. 1987;19(3):221-5. doi: 10.1007/BF00252976.

Cancer Chemother Pharmacol. 1989;25(3):149-55. doi: 10.1007/BF00689574.

Relationship between the pharmacokinetics and toxicity of mitozolomide.

Cancer Chemother Pharmacol. 1990;25(5):352-4. doi: 10.1007/BF00686236.

Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity.

Cancer Chemother Pharmacol. 1990;26(6):429-36. doi: 10.1007/BF02994094.

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).替莫唑胺的I期试验（CCRG 81045：M&B 39831：NSC 362856）。

Br J Cancer. 1992 Feb;65(2):287-91. doi: 10.1038/bjc.1992.57.

A clinical and pharmacological study of high-dose mitozolomide given in conjunction with autologous bone marrow rescue.

Cancer Chemother Pharmacol. 1992;29(3):201-6. doi: 10.1007/BF00686253.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验